
MedCity, the new entity seeking to capitalise on the so-called ‘golden triangle’ of medical and life sciences R&D organisations between …

Alkermes’ investigational schizophrenia drug has met its primary endpoint in a pivotal trial, leading the firm to seek regulatory approval …
The newly named Virgo Consumer Health & Wellbeing welcomes two new joiners – Matthew Coy and Reena Patel (both pictured), …

A US jury has ordered Japanese firm Takeda Pharmaceutical to pay $6 billion (£3.6 billion) in punitive damages, over claims …

inVentiv Health has appointed Michael Griffith as its new executive vice president. In this capacity, Griffith will head inVentiv’s commercial …

PatientsLikeMe has set up a five-year agreement with Genentech, Roche’s biologics arm, to allow the firm access to patients’ real-world …


Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become the …

Generic manufacturer Mylan is suing Celgene in a spat over allowing copycat versions of existing cancer drugs – Revlimid and …

Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …

Roche’s lung cancer drug Tarceva has been given a reprieve to treat relapsed lung cancer patients in the NHS after …

India’s status as a battleground for patent issues has been reinforced with the news that Novartis is suing Biocon over …
Medical communications firm Fishawack has acquired JK Associates in a bid to significantly expand the company’s presence in the US. …

AbbVie will no longer seek to stop the European Medicines Agency from releasing data on its blockbuster arthritis treatment Humira. …

A new three-dimensional atlas of the developing human brain has been made available in the hope that it can help …

Sanofi UK and Ireland’s managing director Steve Oldfield has been elected as chair of the European Medicines Group (EMG). Oldfield …

Researchers have created a new wearable device that is as thin as a temporary tattoo and can store and transmit …

GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …